Andersen Pharmaceutical

China
Anhui, China, Hefei

Company profile

Andersen Pharmaceutical company profile

Andersen Pharmaceutical engages in pharmaceutical R&D, production, and sales. Its research project "National Class 1.1 Anti-tumor Chemical New Drug Taxideptide" has been supported by the Ministry of Science and Technology and the National Health and Family Planning Commission's "Major New Drug Creation" National Major Project (Project No.: 2015ZX09101002), and was approved by the Standing Committee of the 11th National People's Congress. Chairman Huisang Guowei identified it as one of the two innovative drugs to be developed during the country's 13th Five-Year Plan period. In the 4th China Innovation and Entrepreneurship Competition, Anderson Pharmaceuticals stood out among more than 700 enterprises..... For more information, log in to dureach.com to view the full company profile.

Business identity

Operating status
Active
Company type
For Profit
Founded
2009-01-01

Headquarters

Headquarters
Anhui, China, Hefei
Country code
CN
Continent
Asia

Capital profile

Funding and company signals

No public funding data is available for this company.

Founders and investors

No public relation records are available.

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.